이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Alcohol Hand Gel Use in Mbale Regional Referral Hospital: a Cost Effectiveness Evaluation (WardGel)

2016년 10월 12일 업데이트: Sanyu Africa Research Institute

Effectiveness Evaluation of Alcohol Hand Gel Use in Mbale Regional Referral Hospital, Rural Eastern Uganda

Ministry of Health through the National Medical Stores has supplied alcohol-based handgels to the different health facilities in Uganda for the health care providers to use during clinical care. However, constant stock-outs and or limited supplies remains the main constraint faced by the hospitals. Thus the handgels are generally used by a few of the senior health care providers.

The promotion of bedside, antiseptic handrubs largely contributes to the increase in compliance and sustained improvement of hand hygiene compliance reduces Health care acquired infections (HCAIs), but it is not yet established how cost- effective the intervention is in a a rural Ugandan hospital where funds are severely rationed and, which serves over 4 million people in over 15 districts in Uganda. An evaluation of an intervention's cost-effectiveness is a crucial factor in whether the government will be prepared to fund the intervention and sustain it.

This WardGel study thus aims to assess the cost-benefit of providing hand gel for all health care workers in Mbale Regional Referral Hospital.

연구 개요

상태

완전한

상세 설명

The WardGel Study aims to assess the cost- effectiveness of providing handgel for all health care workers in selected wards of Mbale regional Referral Hospital in rural Eastern Uganda.

The WardGel study seeks to address the following specific objectives:-

  1. To determine the incidence of new infections following hospital admission among in-patients
  2. To assess the hand hygiene compliance among the health care providers (HCPs) as the usual practice and with handgel
  3. To determine the effectiveness of handgel in reduction of new infections after hospital admission
  4. To determine the additional costs associated with development of new infections after hospital stay

This study will compare infection rates before (pre-intervention phase) and after implementation of the hand gel for use by health care providers (intervention phase). The study will also assess hand-hygiene compliance amongst health workers and additional costs associated with management of new acquired infections amongst inpatients while at the hospital.

The pre-intervention phase lasting for 12 weeks will involve baseline evaluation of the current hand hygiene practices on each of the study wards, ascertaining how frequently HCPs washed their hands or used handgel.

At the end of 12 weeks, the Intervention will begin and last for 12 weeks. Alcohol-based hand gels will be introduced and provided to health care providers (HCPs) for use before and after each patient care episode.

In ward Training will be provided for all HCPs, including student trainees of clinical medicine and nursing prior to introduction of the hand gels on its use and any promotion messages for example, displaying posters in each hand washing area in the respective wards. Any other training will be arranged and conducted accordingly. 1-Litre handgel bottles will be fitted in the holders fixed to the walls on the wards, and other free bottles placed on the trolleys for using while conducting ward rounds, others on the reception area during the registration of inpatient, and treatment area while administering patients' treatment.

Also 40ml hand-sized bottles will be availed to health care providers. Additional stocks of the hand gel will be available in the staff areas and one central pharmacy area. Compliance with the intervention will be assessed by direct observation by the research assistants on each ward based on the WHO assessment tools and by volume of gel use.

In both phases, the following will be crosscutting: -

  • The study shall adopt the WHO hand hygiene tools (the WHO 5-Moment Tool and hand hygiene compliance tool) to assess the hand hygiene compliance (WHO 2009).
  • Prospective data will also be collected daily from all recruited inpatients on the wards prior to and during the implementation of the intervention to document the frequency of infections on admission and the rate of new acquired infections during their hospital stay.

The new infections definitions acquired after admission of the patients and applied in this WardGel study have been developed and modified from the CDC/NHSN Surveillance definitions for specific infections [CDC 2014].

  • Individual patients data collected from patient interviews will be augmented by a review of their case files.
  • Research assistants will interview all recruited patients and or their carers diagnosed with a new infection to assess the exact extra care costs incurred from patients' perspective. Meanwhile, hospital records shall help to establish the extra costs incurred for antibiotics, and health workers extra time. Other costs will be related hand gel supplies, training and start-up costs.

연구 유형

관찰

등록 (실제)

3626

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Mbale, 우간다
        • Mbale Regional Referral Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

The study population will include in-patients and health care providers on six (6) selected wards (Labour ward, Postnatal ward, Gynaecological ward, Acute Care unit, paediatric Ward, and general surgical wards) The sample will be selected by convenience non-probability sampling method

설명

Inclusion Criteria:

  • Patients is admitted for at least 24 hours
  • Any health care provider, including students

Exclusion Criteria:

  • Patients discharged before 24 hours

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Evidence of Hospital acquired infection confirmed clinically
기간: At least 48 hours after hospital admission or re-admission.Participants will be followed for the duration of hospital stay, an expected average of 5 days.
Hospital acquired infection will be defined as new clinically diagnosed infection developed whilst an inpatient or within 2 days of discharge (for readmitted patients).
At least 48 hours after hospital admission or re-admission.Participants will be followed for the duration of hospital stay, an expected average of 5 days.

2차 결과 측정

결과 측정
측정값 설명
기간
Evidence of Hospital Acquired infection confirmed by laboratory investigations (CBC and C&S)
기간: At least 48 hours after admission or readmission.Participants will be followed for the duration of hospital stay, an expected average of 5 days.
Participants will be followed for the duration of hospital stay, an expected average of 5 days.
At least 48 hours after admission or readmission.Participants will be followed for the duration of hospital stay, an expected average of 5 days.
Hand hygiene compliance by health care providers based on the WHO's 5-moments of Hand hygiene
기간: during patient clinical care.participants will be observed during their clinical care practice, an expected average of 30 minutes per session
participants will be observed during their clinical care practice, an expected average of 30 minutes per session
during patient clinical care.participants will be observed during their clinical care practice, an expected average of 30 minutes per session
cost-effectiveness of hand gel use by micro-economic assessment
기간: Additional period due to confirmed hospital acquired infection.Participants will be followed for the duration of hospital stay, an expected average of 5 days.
Participants will be followed for the duration of hospital stay, an expected average of 5 days.
Additional period due to confirmed hospital acquired infection.Participants will be followed for the duration of hospital stay, an expected average of 5 days.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Andrew Weeks, PhD, University of Liverpool
  • 수석 연구원: James Ditai, MPH, Sanyu Africa Research Institute
  • 수석 연구원: Benon Wanume, MMED (CP), Mbale Regional Referral Hospital
  • 연구 책임자: Julian Abeso, MMED (Paed), Mbale Regional Referral Hospital
  • 연구 책임자: Kyoko Inoue, MPH, Nagasaki University

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2014년 10월 1일

기본 완료 (실제)

2015년 5월 1일

연구 완료 (실제)

2015년 5월 1일

연구 등록 날짜

최초 제출

2015년 4월 20일

QC 기준을 충족하는 최초 제출

2015년 5월 2일

처음 게시됨 (추정)

2015년 5월 6일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2016년 10월 13일

QC 기준을 충족하는 마지막 업데이트 제출

2016년 10월 12일

마지막으로 확인됨

2016년 10월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • SAfRI/OBS/001

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

Infections, Hospital에 대한 임상 시험

구독하다